BackCARsgen Therapeutics Holdings Limited Overview

CARsgen Therapeutics Holdings Limited Inventory

CARsgen Therapeutics Holdings Limited's inventory is $7.2M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$7.23M
↓ 34.95% YoYΔ $-3.89M vs prior year quarter

Peer trimmed avg / median

Loading

CARsgen Therapeutics Holdings Limited Inventory History

Loading

CARsgen Therapeutics Holdings Limited vs. peers: Inventory Comparison

Loading

CARsgen Therapeutics Holdings Limited Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

CARsgen Therapeutics Holdings Limited (2171.HK) FAQ

The latest inventory for 2171.HK is $7.2M as of June 2026. That compares with $11M in the prior-year period — down 34.9% year over year. Investors often review this figure alongside CARsgen Therapeutics Holdings Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, 2171.HK's inventory moved from $11M to $7.2M — a 34.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CARsgen Therapeutics Holdings Limited's operating scale or balance-sheet position.

A inventory figure of $7.2M for 2171.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 2171.HK's inventory ($7.2M), review year-over-year change from $11M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack CARsgen Therapeutics Holdings Limited's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.